补体因子H自身抗体与膜性肾病 - Suppr

Suppr

超能文献

Factor H Autoantibodies and Membranous Nephropathy.

作者信息

Seikrit Claudia, Ronco Pierre, Debiec Hanna

机构信息

INSERM UMR S1155, Paris, France

出版信息

N Engl J Med. 2018 Dec 20;379(25):2479-2481. doi: 10.1056/NEJMc1805857.

DOI:10.1056/NEJMc1805857

PMID:30575481

Abstract

摘要

相似文献

Factor H Autoantibodies and Membranous Nephropathy.补体因子H自身抗体与膜性肾病

N Engl J Med. 2018 Dec 20;379(25):2479-2481. doi: 10.1056/NEJMc1805857.

Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy.在膜性肾病临床表现出现之前，血清抗磷脂酶A2受体（PLA2R）抗体可能已经存在。

Kidney Int. 2016 Jun;89(6):1399. doi: 10.1016/j.kint.2015.11.032.

Human idiopathic membranous nephropathy--a mystery solved?人类特发性膜性肾病——谜团解开了？

N Engl J Med. 2009 Jul 2;361(1):81-3. doi: 10.1056/NEJMe0903343.

Improvement of idiopathic membranous nephropathy diagnosis with ultrasensitive quantitative detection of anti-phospholipase A2 receptor.通过抗磷脂酶A2受体的超灵敏定量检测改善特发性膜性肾病的诊断

J Allergy Clin Immunol. 2017 Jun;139(6):1988-1990.e2. doi: 10.1016/j.jaci.2016.10.020. Epub 2016 Nov 19.

Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.循环抗磷脂酶A2受体自身抗体用于监测膜性肾病的免疫活性。

J Am Soc Nephrol. 2011 Aug;22(8):1400-2. doi: 10.1681/ASN.2011060610. Epub 2011 Jul 22.

Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy.含血小板反应蛋白1型结构域7A相关膜性肾病的临床特征

Ren Fail. 2020 Nov;42(1):966-968. doi: 10.1080/0886022X.2020.1819318.

Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.原发性膜性肾病中人 M 型磷脂酶 A2 受体自身抗体的酶联免疫吸附测定法的建立。

Clin Chim Acta. 2013 Jun 5;421:213-8. doi: 10.1016/j.cca.2013.03.015. Epub 2013 Mar 27.

Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody.利妥昔单抗对伴有抗磷脂酶A2受体抗体滴度持续升高的膜性肾病进行再治疗。

Kidney Int. 2019 Jan;95(1):233-234. doi: 10.1016/j.kint.2018.08.045.

Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.抗磷脂酶A2受体抗体与膜性肾病的免疫抑制：抗磷脂酶A2受体自身抗体致病性的更多证据

J Am Soc Nephrol. 2015 Oct;26(10):2308-11. doi: 10.1681/ASN.2015020181. Epub 2015 Mar 24.

PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.膜性肾病中的PLA2R自身抗体和PLA2R肾小球沉积物

N Engl J Med. 2011 Feb 17;364(7):689-90. doi: 10.1056/NEJMc1011678.

引用本文的文献

Chronic kidney disease enhances alternative pathway activity: a new paradigm.慢性肾脏病增强替代途径活性：一种新范式。

J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI188353.

Therapeutic targets in membranous nephropathy: plasma cells and complement.膜性肾病的治疗靶点：浆细胞与补体

Clin Kidney J. 2024 Aug 13;17(9):sfae243. doi: 10.1093/ckj/sfae243. eCollection 2024 Sep.

A review of progress on complement and primary membranous nephropathy.补体与原发性膜性肾病研究进展述评。

Medicine (Baltimore). 2024 Jul 19;103(29):e38990. doi: 10.1097/MD.0000000000038990.

Proteomic analysis of glomeruli, tubules and renal interstitium in idiopathic membranous nephropathy (IMN): A statistically observational study.特发性膜性肾病（IMN）肾小球、肾小管和肾间质的蛋白质组学分析：一项统计学观察性研究。

Medicine (Baltimore). 2023 Dec 15;102(50):e36476. doi: 10.1097/MD.0000000000036476.

Kidney diseases.肾脏疾病。

Immunol Rev. 2023 Jan;313(1):239-261. doi: 10.1111/imr.13167. Epub 2022 Nov 12.

The role of the complement system in primary membranous nephropathy: A narrative review in the era of new therapeutic targets.补体系统在原发性膜性肾病中的作用：新治疗靶点时代的叙述性综述。

Front Immunol. 2022 Oct 24;13:1009864. doi: 10.3389/fimmu.2022.1009864. eCollection 2022.

The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy.抗-THSD7A 自身抗体通过替代途径激活补体是必要且充分的，而在膜性肾病中，这些自身抗体主要是 IgG4。

Front Immunol. 2022 Jul 7;13:952235. doi: 10.3389/fimmu.2022.952235. eCollection 2022.

Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.膜性肾病患者因补体因子I致病突变导致的移植后血栓性微血管病：病例报告及文献复习

Front Immunol. 2022 May 26;13:909503. doi: 10.3389/fimmu.2022.909503. eCollection 2022.

Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015-2018.2015-2018 年脑膜炎球菌 B 型疫苗（Bexsero®）的安全性监测。疫苗不良事件报告系统。

Vaccine. 2022 Jan 21;40(2):247-254. doi: 10.1016/j.vaccine.2021.11.071. Epub 2021 Dec 7.

Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.肾脏疾病与补体的作用：将补体与免疫效应途径和治疗联系起来。

Adv Immunol. 2021;152:1-81. doi: 10.1016/bs.ai.2021.09.001. Epub 2021 Nov 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验